Skip to main content

Table 3 Associations between HC use and premenstrual symptom severity

From: Hormonal contraceptive use and prevalence of premenstrual symptoms in a multiethnic Canadian population

Symptom

Severity

HC non-users (%)

HC Users (%)

Model 1

Model 1

Model 2

Model 2

N = 782

N = 320

Relative Risk

p-value

Relative Risk

p-value

Acne / Skin Blemish

None

310 (40)

111 (35)

REF

 

REF

 

Mild

318 (41)

161 (50)

1.17 (1.03,1.33)

0.02

1.12 (0.98,1.28)

0.10

Moderate/Severe

154 (20)

48 (15)

0.91 (0.69,1.19)

0.49

0.84 (0.63,1.12)

0.23

Bloating / Swelling / Breast Tenderness

None

207 (26)

71 (22)

REF

 

REF

 

Mild

309 (40)

143 (45)

1.12 (0.99,1.26)

0.07

1.07 (0.95,1.22)

0.27

Moderate/Severe

266 (34)

106 (33)

1.06 (0.92,1.23)

0.39

1.00 (0.86,1.16)

0.99

Cramps

None

185 (24)

89 (28)

REF

 

REF

 

Mild

256 (33)

128 (40)

1.02 (0.89,1.16)

0.82

0.93 (0.81,1.07)

0.29

Moderate/Severe

341 (44)

103 (32)

0.83 (0.72,0.96)

0.01

0.82 (0.71,0.93)

0.002

Mood Swings / Crying Easily / Irritability /Angry Outbursts

None

212 (27)

92 (29)

REF

 

REF

 

Mild

287 (37)

128 (40)

1.01 (0.88,1.16)

0.87

1.02 (0.88,1.18)

0.80

Moderate/Severe

283 (36)

100 (31)

0.91 (0.78,1.06)

0.24

0.89 (0.76,1.06)

0.19

Increased Appetite / Food Cravings

None

282 (36)

112 (35)

REF

 

REF

 

Mild

232 (30)

107 (33)

1.08 (0.91,1.28)

0.35

1.06 (0.89,1.27)

0.49

Moderate/Severe

268 (34)

101 (32)

0.97 (0.82,1.15)

0.75

0.97 (0.82,1.16)

0.76

Fatigue

None

342 (44)

153 (48)

REF

 

REF

 

Mild

245 (31)

107 (33)

0.99 (0.83,1.17)

0.87

1.00 (0.83,1.20)

0.97

Moderate/Severe

195 (25)

60 (19)

0.78 (0.61,0.99)

0.04

0.82 (0.64,1.05)

0.11

Headache

None

575 (74)

231 (72)

REF

 

REF

 

Mild

131 (17)

58 (18)

1.08 (0.82,1.43)

0.58

1.11 (0.84,1.49)

0.46

Moderate/Severe

76 (10)

31 (10)

1.01 (0.68,1.50)

0.95

1.01 (0.67,1.51)

0.97

Anxiety / Tension / Nervousness

None

480 (61)

220 (69)

REF

 

REF

 

Mild

201 (26)

73 (23)

0.84 (0.67,1.06)

0.15

0.88 (0.69,1.13)

0.31

Moderate/Severe

101 (13)

27 (8)

0.63 (0.42,0.94)

0.02

0.63 (0.42,0.95)

0.03

Clumsiness

None

655 (84)

278 (87)

REF

 

REF

 

Mild

90 (12)

39 (12)

1.02 (0.72,1.45)

0.92

1.07 (0.74,1.56)

0.71

Moderate/Severe

37 (5)

3 (1)

0.20 (0.06,0.64)

0.007

0.22 (0.07,0.73)

0.01

Confusion / Difficulty Concentrating / Forgetfulness

None

599 (77)

267 (83)

REF

 

REF

 

Mild

121 (15)

48 (15)

0.91 (0.67,1.23)

0.53

1.00 (0.72,1.38)

1.00

Moderate/Severe

62 (8)

5 (2)

0.20 (0.08,0.48)

0.0004

0.22 (0.09,0.54)

0.001

Sexual Desire / Activity Change

None

407 (52)

147 (46)

REF

 

REF

 

Mild

233 (30)

112 (35)

1.19 (1.00,1.41)

0.05

1.14 (0.95,1.37)

0.16

Moderate/Severe

142 (18)

61 (19)

1.13 (0.88,1.46)

0.33

0.96 (0.74,1.23)

0.74

Insomnia

None

688 (88)

293 (92)

REF

 

REF

 

Mild

75 (10)

25 (8)

0.80 (0.52,1.23)

0.31

0.91 (0.57,1.43)

0.68

Moderate/Severe

19 (2)

2 (1)

0.25 (0.06,1.08)

0.06

0.23 (0.05,0.99)

0.05

Nauseaa

None

664 (85)

277 (87)

REF

 

REF

 

Mild

81 (10)

35 (10)

1.03 (0.71,1.50)

0.87

0.95 (0.64,1.41)

0.80

Moderate/Severe

37 (5)

8 (3)

0.53 (0.25,1.13)

0.10

N/A

N/A

Depression

None

543 (69)

236 (74)

REF

 

REF

 

Mild

150 (19)

65 (20)

1.00 (0.77,1.29)

0.99

0.96 (0.73,1.26)

0.77

Moderate/Severe

89 (11)

19 (6)

0.53 (0.33,0.85)

0.008

0.55 (0.34,0.90)

0.02

Desire to be alone

None

499 (64)

238 (75)

REF

 

REF

 

Mild

180 (23)

62 (19)

0.78 (0.60,1.01)

0.06

0.80 (0.62,1.04)

0.10

Moderate/Severe

103 (13)

19 (6)

0.43 (0.27,0.69)

0.0004

0.45 (0.28,0.73)

0.001

  1. Model 1 contains unadjusted relative risks and p-values
  2. Model 2 contains relative risks and p-values adjusted for ethnicity, log-transformed BMI, physical activity, age, and medication use
  3. aindicates no values obtained in Model 2 due to low sample size